Abstract
The term fetal cell microchimerism (FCM) indicates the persistence of fetal cells in the mother for decades after pregnancy. These cells engraft the maternal bone marrow and are able to migrate through the circulation and to reach tissues in case of damage. In animal models, a beneficial effect of microchimeric cells in the repair of tissues after injury is documented. In humans, the possible role of fetal microchimeric cells is still controversial, particularly in the cancer field. At the peripheral blood level, FCM is less frequently observed in parous women affected with cancer than in healthy controls, suggesting a beneficial role in cancer surveillance. At the tissue level, several studies propose a protective and repair function for FCM, whereas others hypothesize a role in the progression of the disease. Interestingly, fetal microchimeric cells are able to transdifferentiate along different lineages. In particular, fetal cells expressing epithelial markers are hypothesized to have a repair function, those positive for hematopoietic markers to have a role in the attack of tumor cells, whereas those displaying an endothelial phenotype to favor tumor progression.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Stevens AM, Hermes HM, Lambert NC, Nelson JL, Meroni PL, Cimaz R. Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block. Rheumatology (Oxford). 2005;44:187–91.
Sato T, Fujimori K, Sato A, Ohto H. Microchimerism after induced or spontaneous abortion. Obstet Gynecol. 2008;112:593–7.
Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum. 2003;48:3237–41.
Peterson SE, Nelson JL, Gadi VK, Gammill HS. Fetal cellular microchimerism in miscarriage and pregnancy termination. Chimerism. 2013;4:136–8.
Gammill HS, Stephenson MD, Aydelotte TM, Nelson JL. Microchimerism in recurrent miscarriage. Cell Mol Immunol. 2014;11:589–94.
Seppanen E, Fisk NM, Khosrotehrani K. Pregnancy-acquired fetal progenitor cells. J Reprod Immunol. 2013;97:27–35.
Gammill HS, Guthrie KA, Aydelotte TM, Adams Waldorf KM, Nelson JL. Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host? Blood. 2010;116:2706–12.
Mold JE, Michaëlsson J, Burt TD, Muench MO, Beckerman KP, Busch MP, Lee TH, Nixon DF, McCune JM. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science. 2008;322:1562–5.
Gammill HS, Adams Waldorf KM, Aydelotte TM, Lucas J, Leisenring WM, Lambert NC, Nelson JL. Pregnancy, microchimerism, and the maternal grandmother. PLoS One. 2011;6:e24101.
Cirello V, Perrino M, Colombo C, Muzza M, Filopanti M, Vicentini L, Beck-Peccoz P, Fugazzola L. Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissues. Int J Cancer. 2010;126:2874–8.
Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, Furst DE, Nelson JL. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum. 2004;50:906–14.
Khosrotehrani K, Stroh H, Bianchi DW, Johnson KL. Combined FISH and immunolabeling on paraffin-embedded tissue sections for the study of microchimerism. Biotechniques. 2003;34(2):242–4.
Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, Lee TH. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion. 2001;41:1524–30.
Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A. 1996;93:705–8.
O’Donoghue K, Chan J, de la Fuente J, Kennea N, Sandison A, Anderson JR, Roberts IA, Fisk NM. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet. 2004;364:179–82.
Lambert NC, Lo YM, Erickson TD, Tylee TS, Guthrie KA, Furst DE, Nelson JL. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood. 2002;100:2845–51.
Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood. 1999;93:2033–7.
Khosrotehrani K, Bianchi DW. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci. 2005;118:1559–63.
Parant O, Dubernard G, Challier JC, Oster M, Uzan S, Aractingi S, Khosrotehrani K. CD34+ cells in maternal placental blood are mainly fetal in origin and express endothelial markers. Lab Investig. 2009;89:915–23.
Kara RJ, Bolli P, Karakikes I, Matsunaga I, Tripodi J, Tanweer O, Altman P, Shachter NS, Nakano A, Najfeld V, Chaudhry HW. Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res. 2012;110:82–93.
Rijnink EC, Penning ME, Wolterbeek R, Wilhelmus S, Zandbergen M, van Duinen SG, Schutte J, Bruijn JA, Bajema IM. Tissue microchimerism is increased during pregnancy: a human autopsy study. Mol Hum Reprod. 2015;21:857–64.
Fujiki Y, Johnson KL, Tighiouart H, Peter I, Bianchi DW. Fetomaternal trafficking in the mouse increases as delivery approaches and is highest in the maternal lung. Biol Reprod. 2008;79:841–8.
Johnson KL, Bianchi DW. Fetal cells in maternal tissue following pregnancy: what are the consequences? Hum Reprod Update. 2004;10:497–502.
Sunami R, Komuro M, Yuminamochi T, Hoshi K, Hirata S. Fetal cell microchimerism develops through the migration of fetus-derived cells to the maternal organs early after implantation. J Reprod Immunol. 2010;84:117–23.
Khosrotehrani K, Reyes RR, Johnson KL, Freeman RB, Salomon RN, Peter I, Stroh H, Guégan S, Bianchi DW. Fetal cells participate over time in the response to specific types of murine maternal hepatic injury. Hum Reprod. 2007;22:654–61.
Khosrotehrani K, Leduc M, Bachy V, Nguyen Huu S, Oster M, Abbas A, Uzan S, Aractingi S. Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers. J Immunol. 2008;180(2):889–97.
Nguyen Huu S, Oster M, Uzan S, Chareyre F, Aractingi S, Khosrotehrani K. Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. Proc Natl Acad Sci U S A. 2007;104:1871–6.
Nguyen Huu S, Khosrotehrani K, Oster M, Moguelet P, Espié MJ, Aractingi S. Early phase of maternal skin carcinogenesis recruits long-term engrafted fetal cells. Int J Cancer. 2008;123:2512.
Nguyen Huu S, Oster M, Avril MF, Boitier F, Mortier L, Richard MA, Kerob D, Maubec E, Souteyrand P, Moguelet P, Khosrotehrani K, Aractingi S. Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy. Am J Pathol. 2009;174:630–7.
Tan XW, Liao H, Sun L, Okabe M, Xiao ZC, Dawe GS. Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier? Stem Cells. 2005;23:1443–52.
Zeng XX, Tan KH, Yeo A, Sasajala P, Tan X, Xiao ZC, Dawe G, Udolph G. Pregnancy-associated progenitor cells differentiate and mature into neurons in the maternal brain. Stem Cells Dev. 2010;19:1819–30.
Wang Y, Iwatani H, Ito T, Horimoto N, Yamato M, Matsui I, Imai E, Hori M. Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun. 2004;325:961–7.
Dubernard G, Aractingi S, Oster M, Rouzier R, Mathieu MC, Uzan S, Khosrotehrani K. Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res. 2008;10:R14.
Dubernard G, Oster M, Chareyre F, Antoine M, Rouzier R, Uzan S, Aractingi S, Khosrotehrani K. Increased fetal cell microchimerism in high grade breast carcinomas occurring during pregnancy. Int J Cancer. 2009;124:1054–9.
Castela M, Nassar D, Sbeih M, Jachiet M, Wang Z, Aractingi S. Ccl2/Ccr2 signalling recruits a distinct fetal microchimeric population that rescues delayed maternal wound healing. Nat Commun. 2017;8:15463.
Tokita K, Terasaki P, Maruya E, Saji H. Tumor regression following stem cell infusion from daughter to microchimeric mother. Lancet. 2001;358:2047–8.
Cha D, Khosrotehrani K, Kim Y, Stroh H, Bianchi DW, Johnson KL. Cervical cancer and microchimerism. Obstet Gynecol. 2003;102:774–81.
Gadi VK, Nelson JL. Fetal microchimerism in women with breast cancer. Cancer Res. 2007;67:9035–8.
Gadi VK, Malone KE, Guthrie KA, Porter PL, Nelson JL. Case-control study of fetal microchimerism and breast cancer. PLoS One. 2008;3:e1706.
Gadi VK. Fetal microchiemrism in breast from women with and without breast cancer. Breast Cancer Res Treat. 2010;121:241–4.
Cirello V, Recalcati MP, Muzza M, Rossi S, Perrino M, Vicentini L, Beck-Peccoz P, Finelli P, Fugazzola L. Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair. Cancer Res. 2008;68:8482–8.
Cirello V, Colombo C, Perrino M, De Leo S, Muzza M, Maffini MA, Fugazzola L. Fetal cell microchimerism in papillary thyroid cancer: a role in the outcome of the disease. Int J Cancer. 2015;137:2989–93.
Gilmore GL, Haq B, Shadduck RK, Jasthy SL, Lister J. Fetal-maternal microchimerism in normal parous females and parous female cancer patients. Exp Hematol. 2008;36:1073–7.
O’Donoghue K, Sultan HA, Al-Allaf FA, Anderson JR, Wyatt-Ashmead J, Fisk NM. Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy. Reprod Biomed Online. 2008;16:382–90.
Khosrotehrani K, Nguyen Huu S, Prignon A, Avril MF, Boitier F, Oster M, Mortier L, Richard MA, Maubec E, Kerob D, Mansard S, Merheb C, Moguelet P, Nassar D, Guegan S, Aractingi S. Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis. Am J Pathol. 2011;178:1870–80.
Kamper-Jørgensen M, Biggar RJ, Tjønneland A, Hjalgrim H, Kroman N, Rostgaard K, Stamper CL, Olsen A, Andersen AM, Gadi VK. Opposite effects of microchimerism on breast and colon cancer. Eur J Cancer. 2012;48:2227–35.
Dhimolea E, Denes V, Lakk M, Al-Bazzaz S, Aziz-Zaman S, Pilichowska M, Geck P. High male chimerism in the female breast shows quantitative links with cancer. Int J Cancer. 2013;133:835–42.
Eun JK, Guthrie KA, Zirpoli G, Gadi VK. In situ breast cancer and microchimerism. Sci Rep. 2013;3:2192.
Hromadnikova I, Kotlabova K, Pirkova P, Libalova P, Vernerova Z, Svoboda B, Kucera E. The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses. DNA Cell Biol. 2014;33:40–8.
Nemescu D, Ursu RG, Nemescu ER, Negura L. Heterogeneous distribution of fetal microchimerism in local breast cancer environment. PLoS One. 2016;11:e0147675.
Jolis TW, Brucker BM, Schorl C, Butera JN, Quesenberry PJ. Low microchimeric cell density in tumors suggests alternative antineoplastic mechanism. Med Oncol. 2017;34:65.
Broestl L, Rubin JB, Dahiya S. Fetal microchimerism in human brain tumors. Brain Pathol. 2017. https://doi.org/10.1111/bpa.12557. [Epub ahead of print].
Thliveris AT, Schwefel B, Clipson L, Plesh L, Zahm CD, Leystra AA, Washington MK, Sullivan R, Deming DA, Newton MA, Halberg RB. Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumors. Proc Natl Acad Sci U S A. 2013;110:11523–8.
Kamper-Jørgensen M. Microchimerism and survival after breast and colon cancer diagnosis. Chimerism. 2012;3:72–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Cirello, V., Fugazzola, L. (2018). Cancer. In: Draper, N. (eds) Chimerism. Springer, Cham. https://doi.org/10.1007/978-3-319-89866-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-89866-7_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89865-0
Online ISBN: 978-3-319-89866-7
eBook Packages: MedicineMedicine (R0)